These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Use of 4-heptylumbelliferyl-beta-D-glucoside to identify Gaucher's disease heterozygotes. Butcher BA; Gopalan V; Lee RE; Richards TC; Waggoner AS; Glew RH Clin Chim Acta; 1989 Oct; 184(3):235-42. PubMed ID: 2515009 [TBL] [Abstract][Full Text] [Related]
9. Three-layer poly(methyl methacrylate) microsystem for analysis of lysosomal enzymes for diagnostic purposes. Kwapiszewski R; Kwapiszewska K; Kutter JP; Brzozka Z Anal Chim Acta; 2015 Jan; 853():702-709. PubMed ID: 25467521 [TBL] [Abstract][Full Text] [Related]
10. 4-Pentafluoroethylumbelliferyl-beta-D-glucoside as a new fluorogenic substrate for acid beta-D-glucosidase. Tsvetkova IV; Karpova EA; Dudukina TV; Voznyi YV Clin Chim Acta; 1996 Apr; 248(2):125-33. PubMed ID: 8740577 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous intracellular β-D-glucosidase and phosphodiesterase I activities measurements based on a triple-signaling fluorescent probe. Li Y; Wang H; Li J; Zheng J; Xu X; Yang R Anal Chem; 2011 Feb; 83(4):1268-74. PubMed ID: 21244038 [TBL] [Abstract][Full Text] [Related]
13. Biochemical study on beta-glucosidase in individuals with Gaucher's disease and normal subjects. Michelin K; Wajner A; Goulart Lda S; Fachel AA; Pereira ML; de Mello AS; Souza FT; Pires RF; Giugliani R; Coelho JC Clin Chim Acta; 2004 May; 343(1-2):145-53. PubMed ID: 15115687 [TBL] [Abstract][Full Text] [Related]
14. Synthetic substrate beta-glucosidase activity in leukocytes: a reproducible method for the identification of patients and carriers of Gaucher's disease. Wenger DA; Clark C; Sattler M; Wharton C Clin Genet; 1978 Feb; 13(2):145-53. PubMed ID: 23912 [TBL] [Abstract][Full Text] [Related]
15. Comparison of various beta-glucosidase assays used to diagnose Gaucher's disease. Chiao YB; Glew RH; Diven WF; Lee RE Clin Chim Acta; 1980 Jul; 105(1):41-50. PubMed ID: 6772352 [No Abstract] [Full Text] [Related]
16. Pitfalls in the use of artificial substrates for the diagnosis of Gaucher's disease. Ben-Yoseph Y; Nadler HL J Clin Pathol; 1978 Nov; 31(11):1091-3. PubMed ID: 105017 [TBL] [Abstract][Full Text] [Related]
17. Gaucher's disease II. Studies on the kinetics of beta-glucosidase and the effects of sodium taurocholate in normal and Gaucher tissues. Choy FY; Davidson RG Pediatr Res; 1980 Jan; 14(1):54-9. PubMed ID: 6767218 [TBL] [Abstract][Full Text] [Related]
18. Neuropathic Gaucher's disease with normal 4-methylumbelliferyl-beta-glucosidase activity in the liver. Owada M; Sakiyama T; Kitagawa T Pediatr Res; 1977 May; 11(5):641-6. PubMed ID: 870871 [TBL] [Abstract][Full Text] [Related]
19. Imprint cytology of Gaucher's disease presenting as a splenic mass. A case report with molecular approaches. Kobayashi TK; Tamagaki T; Yoneyama C; Watanabe S; Sugihara H; Ida H Acta Cytol; 1998; 42(2):419-24. PubMed ID: 9568149 [TBL] [Abstract][Full Text] [Related]
20. Fluorescent flow cytometric assay: a new diagnostic tool for measuring beta-glucocerebrosidase activity in Gaucher disease. Rudensky B; Paz E; Altarescu G; Raveh D; Elstein D; Zimran A Blood Cells Mol Dis; 2003; 30(1):97-9. PubMed ID: 12667991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]